{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:42:05Z","timestamp":1784241725407,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:00:00Z","timestamp":1715904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017412","name":"Becton Dickinson and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.gore.2024.101421","type":"journal-article","created":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T16:27:32Z","timestamp":1716654452000},"page":"101421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Variables that impact HPV test accuracy during vaginal self collection workflow for cervical cancer screening"],"prefix":"10.1016","volume":"54","author":[{"given":"Laurence","family":"Vaughan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin","family":"Gary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Millie","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndsay","family":"Lewellen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Galbraith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Parvu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gore.2024.101421_b0005","article-title":"Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses","volume":"363","author":"Arbyn","year":"2018","journal-title":"BMJ (clinical Research Ed)."},{"key":"10.1016\/j.gore.2024.101421_b0010","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jcv.2018.08.006","article-title":"VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples","volume":"107","author":"Arbyn","year":"2018","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.gore.2024.101421_b0015","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ijc.33189","article-title":"The European response to the WHO call to eliminate cervical cancer as a public health problem","volume":"148","author":"Arbyn","year":"2021","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.gore.2024.101421_b0020","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/ijc.33967","article-title":"Meta-analysis of agreement\/concordance statistics in studies comparing self- vs clinician-collected samples for HPV testing in cervical cancer screening","volume":"151","author":"Arbyn","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.gore.2024.101421_b0025","unstructured":"BD SurePath\u2122 Collection [package insert]. Becton, Dickinson and Company, Burlington, NC; 2011. DOI."},{"key":"10.1016\/j.gore.2024.101421_b0030","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1002\/cam4.3951","article-title":"A population study of screening history and diagnostic outcomes of women with invasive cervical cancer","volume":"10","author":"Benard","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.gore.2024.101421_b0035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00128360-200307000-00003","article-title":"Keeping collecting device in liquid medium is mandatory to ensure optimized liquid-based cervical cytologic sampling","volume":"7","author":"Bigras","year":"2003","journal-title":"J Low Genit Tract Dis."},{"key":"10.1016\/j.gore.2024.101421_b0040","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/14737159.2019.1622415","article-title":"Profile of the BD HPV OnclarityTM assay","volume":"19","author":"Bottari","year":"2019","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.gore.2024.101421_b0045","doi-asserted-by":"crossref","first-page":"e1115","DOI":"10.1016\/S2214-109X(22)00241-8","article-title":"Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis","volume":"10","author":"Bruni","year":"2022","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.gore.2024.101421_b0050","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1158\/1055-9965.EPI-20-1226","article-title":"A randomized comparison of different vaginal self-sampling devices and urine for human papillomavirus testing-predictors 5.1","volume":"30","author":"Cadman","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"10.1016\/j.gore.2024.101421_b0055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13027-020-00311-w","article-title":"A comparison of screening tests for detection of high-grade cervical abnormalities in women living with HIV from Cameroon","volume":"15","author":"Castle","year":"2020","journal-title":"Infectious Agents and Cancer."},{"key":"10.1016\/j.gore.2024.101421_b0060","doi-asserted-by":"crossref","first-page":"829","DOI":"10.4143\/crt.2020.1165","article-title":"Performance and diagnostic accuracy of human papillomavirus testing on self-collected urine and vaginal samples in a referral population","volume":"53","author":"Cho","year":"2021","journal-title":"Cancer Res Treat."},{"key":"10.1016\/j.gore.2024.101421_b0065","unstructured":"Cocuzza, C., Arbyn, M. 2023. Personal communication. Sensitivity and specificity of HPV assays for high-grade cervical precancer on vaginal self-samples compared to cervical samples taken by a clinician. November 10, 2021. 2023. DOI."},{"key":"10.1016\/j.gore.2024.101421_b0070","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2144\/btn-2022-0084","article-title":"Influence of resuspension volume on dry sampling devices taken for human papillomavirus testing: implications for self-sampling","volume":"74","author":"Connor","year":"2023","journal-title":"Biotechniques"},{"key":"10.1016\/j.gore.2024.101421_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2021.104756","article-title":"The challenges of defining sample adequacy in an era of HPV based cervical screening","volume":"137","author":"Cuschieri","year":"2021","journal-title":"J Clin Virol."},{"key":"10.1016\/j.gore.2024.101421_b0080","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13690-021-00667-4","article-title":"Cervical cancer screening using HPV tests on self-samples: attitudes and preferences of women participating in the VALHUDES study","volume":"79","author":"De Pauw","year":"2021","journal-title":"Arch Public Health."},{"key":"10.1016\/j.gore.2024.101421_b0085","article-title":"The natural history of human papillomavirus infection","author":"de Sanjose","year":"2017","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"key":"10.1016\/j.gore.2024.101421_b0090","doi-asserted-by":"crossref","first-page":"8","DOI":"10.35755\/jmedassocthai.2023.01.13727","article-title":"Comparison of self- to provider-collected cervical screening with HPV DNA test at roi et province, thailand during COVID-19 pandemic","volume":"106","author":"Eamratsameekool","year":"2023","journal-title":"J. Med. Assoc. Thai."},{"key":"10.1016\/j.gore.2024.101421_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2022.107096","article-title":"Operational experiences from the general implementation of HPV self-sampling to Danish screening non-attenders","volume":"160","author":"Ejegod","year":"2022","journal-title":"Prev Med."},{"key":"10.1016\/j.gore.2024.101421_b0100","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ygyno.2018.04.004","article-title":"Validation of a new HPV self-sampling device for cervical cancer screening: the cervical and self-sample in screening (CASSIS) study","volume":"149","author":"El-Zein","year":"2018","journal-title":"Gynecol Oncol."},{"key":"10.1016\/j.gore.2024.101421_b0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph181910388","article-title":"CoCoss-Trial: Concurrent Comparison of Self-Sampling Devices for HPV-Detection","volume":"18","author":"Ertik","year":"2021","journal-title":"Int J Environ Res Public Health."},{"key":"10.1016\/j.gore.2024.101421_b0110","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4314\/mmj.v30i2.2","article-title":"Feasibility, validity and acceptability of self-collected samples for human papillomavirus (HPV) testing in rural Malawi","volume":"30","author":"Esber","year":"2018","journal-title":"Malawi Med J."},{"key":"10.1016\/j.gore.2024.101421_b0115","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3322\/caac.21628","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society","volume":"70","author":"Fontham","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.gore.2024.101421_b0120","first-page":"111","article-title":"Performance and pre-analytical stability of self-collected samples versus clinician cervical samples for the detection of HPV16, HPV18 and a pool of 12 other HPV types on the Roche Cobas 8800 System","volume":"45","author":"Ilardo","year":"2022","journal-title":"New Microbiol."},{"key":"10.1016\/j.gore.2024.101421_b0125","article-title":"Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: An observational study","volume":"11","author":"Inturrisi","year":"2021","journal-title":"Lancet Reg Health Eur."},{"key":"10.1016\/j.gore.2024.101421_b0130","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/bjc.2017.371","article-title":"High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders","volume":"118","author":"Lam","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.gore.2024.101421_b0135","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1158\/1055-9965.EPI-22-0757","article-title":"Validation of BD onclarity HPV assay on vaginal self-samples versus cervical samples using the VALHUDES protocol","volume":"31","author":"Latsuzbaia","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"10.1016\/j.gore.2024.101421_b0140","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01631-22","article-title":"Clinical performance of the realtime high risk HPV assay on self-collected vaginal samples within the VALHUDES framework","volume":"10","author":"Latsuzbaia","year":"2022","journal-title":"Microbiol Spectr."},{"key":"10.1016\/j.gore.2024.101421_b0145","article-title":"Comparison of the clinical accuracy of Xpert HPV assay on vaginal self-samples and cervical clinician-taken samples within the VALHUDES framework","author":"Latsuzbaia","year":"2023","journal-title":"J Mol Diagn."},{"key":"10.1016\/j.gore.2024.101421_b0150","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12985-023-02073-4","article-title":"The features of high-risk human papillomavirus infection in different female genital sites and impacts on HPV-based cervical cancer screening","volume":"20","author":"Li","year":"2023","journal-title":"Virol. J."},{"key":"10.1016\/j.gore.2024.101421_b0155","first-page":"12","article-title":"Evaluation of BD onclarity HPV assay on self-collected vaginal and first-void urine samples as compared to clinician-collected cervical samples: a pilot study","author":"Martinelli","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.gore.2024.101421_b0160","first-page":"e02872","article-title":"Performance of BD Onclarity HPV assay on FLOQSwabs vaginal self-samples","author":"Martinelli","year":"2024","journal-title":"Microbiol Spectr."},{"key":"10.1016\/j.gore.2024.101421_b0165","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older","volume":"124","author":"Meijer","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.gore.2024.101421_b0170","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1007\/s10147-020-01727-5","article-title":"Evaluation of the concordance in HPV type between self- and physician-collected samples using a brush-based device and a PCR-based HPV DNA test in Japanese referred patients with abnormal cytology or HPV infection","volume":"25","author":"Onuma","year":"2020","journal-title":"Int J Clin Oncol."},{"key":"10.1016\/j.gore.2024.101421_b0175","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1470-2045(18)30763-0","article-title":"Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial","volume":"20","author":"Polman","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.gore.2024.101421_b0180","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/path.3970","article-title":"One virus, one lesion\u2013individual components of CIN lesions contain a specific HPV type","volume":"227","author":"Quint","year":"2012","journal-title":"J Pathol."},{"key":"10.1016\/j.gore.2024.101421_b0185","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01443-19","article-title":"Test accuracy of human papillomavirus in urine for detection of cervical intraepithelial neoplasia","volume":"58","author":"Rohner","year":"2020","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.gore.2024.101421_b0190","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1158\/1055-9965.EPI-20-0674","article-title":"Extended HPV genotyping to compare HPV type distribution in self- and provider-collected samples for cervical cancer screening","volume":"29","author":"Rohner","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"10.1016\/j.gore.2024.101421_b0195","first-page":"154","article-title":"Worldwide use of HPV self-sampling for cervical cancer screening","author":"Serrano","year":"2022","journal-title":"Prev. Med."},{"key":"10.1016\/j.gore.2024.101421_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106900","article-title":"Worldwide use of HPV self-sampling for cervical cancer screening","volume":"154","author":"Serrano","year":"2022","journal-title":"Prev Med."},{"key":"10.1016\/j.gore.2024.101421_b0205","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/ijc.33888","article-title":"Self-sampling as the principal modality for population based cervical screening: Five-year follow-up of the PaVDaG study","volume":"150","author":"Stanczuk","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.gore.2024.101421_b0210","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ygyno.2018.04.007","article-title":"The onclarity human papillomavirus trial: design, methods, and baseline results","volume":"149","author":"Stoler","year":"2018","journal-title":"Gynecol Oncol."},{"key":"10.1016\/j.gore.2024.101421_b0215","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1007\/s10147-022-02238-1","article-title":"Human papillomavirus testing and cytology using physician-collected uterine cervical samples vs. self-collected vaginal samples and urine samples","volume":"27","author":"Terada","year":"2022","journal-title":"Int J Clin Oncol."},{"key":"10.1016\/j.gore.2024.101421_b0220","unstructured":"ThinPrep\u00ae Pap Test PreservCyt\u00ae Solution [package insert]. Hologic, Inc. Marlborough, MA; 2019. DOI."},{"key":"10.1016\/j.gore.2024.101421_b0225","article-title":"Evaluation of p16\/Ki-67 dual stain cytology performed on self-collected vaginal and clinician-collected cervical specimens for the detection of cervical pre-cancer","author":"Toliman","year":"2019","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.gore.2024.101421_b0230","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s12879-018-3254-y","article-title":"Good concordance of HPV detection between cervico-vaginal self-samples and general practitioner-collected samples using the Cobas 4800 HPV DNA test","volume":"18","author":"Tranberg","year":"2018","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.gore.2024.101421_b0235","unstructured":"UWHealth. PAP AND HPV TESTING FREQUENTLY ASKED QUESTIONS https:\/\/bynderuwhealthorg\/m\/1f845e4bbdcea068\/original\/PAP-and-HPV-Testing-FAQpdf. 2016. DOI."},{"key":"10.1016\/j.gore.2024.101421_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2022.105271","article-title":"Analytical and clinical performance of extended HPV genotyping with BD Onclarity HPV Assay in home-collected first-void urine: A diagnostic test accuracy study","volume":"155","author":"Van Keer","year":"2022","journal-title":"J Clin Virol."},{"key":"10.1016\/j.gore.2024.101421_b0245","unstructured":"WHO: New recommendations for screening and treatment to prevent cervical cancer. https:\/\/www.who.int\/news\/item\/06-07-2021-new-recommendations-for-screening-and-treatment-to-prevent-cervical-cancer, 2021. DOI."},{"key":"10.1016\/j.gore.2024.101421_b0250","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.02048-20","article-title":"Analytical and clinical sample performance characteristics of the onclarity assay for the detection of human papillomavirus","volume":"59","author":"Young","year":"2020","journal-title":"J Clin Microbiol."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578924001000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578924001000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T07:44:31Z","timestamp":1722239071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578924001000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":50,"alternative-id":["S2352578924001000"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2024.101421","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variables that impact HPV test accuracy during vaginal self collection workflow for cervical cancer screening","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2024.101421","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101421"}}